IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.

Saved in:
Bibliographic Details
Title: IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression.
Authors: Ohmatsu H; Laboratory for Investigative Dermatology, The Rockefeller University , New York, NY, USA., Humme D; Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité- Universitätsmedizin Berlin , Berlin, Germany., Gonzalez J; Rockefeller University Center for Clinical and Translational Science , New York, NY, USA., Gulati N; Laboratory for Investigative Dermatology, The Rockefeller University , New York, NY, USA., Möbs M; Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité- Universitätsmedizin Berlin , Berlin, Germany., Sterry W; Department of Dermatology and Allergy, Skin Cancer Center Charité, Charité- Universitätsmedizin Berlin , Berlin, Germany., Krueger JG; Laboratory for Investigative Dermatology, The Rockefeller University , New York, NY, USA.
Source: Oncoimmunology [Oncoimmunology] 2016 May 05; Vol. 6 (2), pp. e1181237. Date of Electronic Publication: 2016 May 05 (Print Publication: 2017).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2162-4011
DOI:10.1080/2162402X.2016.1181237